Chembond Chemicals Posts 11.59% Revenue Growth, Recommends ₹1.25 Dividend

INDUSTRIAL-GOODSSERVICES
Whalesbook Corporate News Logo
AuthorRiya Kapoor|Published at:
Chembond Chemicals Posts 11.59% Revenue Growth, Recommends ₹1.25 Dividend

Chembond Chemicals reported an 11.59% rise in consolidated revenue to ₹326.15 crore for FY 2025-26. The company also recommended a final dividend of ₹1.25 per share, showcasing a strong financial performance with zero debt.

Chembond Chemicals Reports Strong FY26 Performance, Recommends ₹1.25 Dividend

Consolidated Revenue grew 11.59% to ₹326.15 crore; Consolidated Profit After Tax up 12.51% to ₹34.78 crore.

Reader Takeaway: Financial discipline and growth drivers are positive; macro headwinds and market concentration are key concerns.

What just happened

Chembond Chemicals Ltd announced its financial results for the fiscal year 2025-26, reporting a consolidated revenue of ₹326.15 crore, an increase of 11.59% over the previous year. Consolidated Profit After Tax (PAT) grew by 12.51% to ₹34.78 crore. The company's Board of Directors has recommended a final dividend of ₹1.25 per equity share.

Why this matters

The results indicate a solid financial performance for Chembond Chemicals as an independently listed entity. The revenue and profit growth, coupled with a strong balance sheet (zero debt-to-equity ratio) and a recommended dividend, are positive signals for shareholders. The company's performance is driven by demand in water technologies and efficiency in construction chemicals.

The backstory

Chembond Chemicals recently completed a demerger from Chembond Material Technologies Ltd in July 2025, leading to its independent listing on the BSE and NSE. This marks its first full fiscal year reporting as a separate entity. The company has been actively managing its subsidiary operations, including a shareholding transfer in Rewasoft Solutions Pvt Ltd effective January 1, 2026.

What changes now

With these results, Chembond Chemicals demonstrates its capability to drive growth and profitability post-demerger. The zero debt position provides financial flexibility. Shareholders can look forward to a dividend payout, subject to AGM approval. The focus will be on sustained growth and managing external economic factors.

Risks to watch

Management has highlighted concerns regarding global macro headwinds, geopolitical uncertainties, and volatility in raw material prices. Additionally, customer and market concentration risks require continuous monitoring and mitigation strategies.

Peer comparison

While specific peer financial data for the same period is not provided in the filing, Chembond's reported zero debt-to-equity ratio and a healthy current ratio of 5.10x suggest a strong and conservative financial structure compared to industry averages which may carry higher leverage.

Context metrics (time-bound)

For FY 2025-26:

  • Consolidated Revenue: ₹326.15 crore (up 11.59% YoY)
  • Consolidated PAT: ₹34.78 crore (up 12.51% YoY)
  • Standalone Revenue: ₹73.65 crore (up 6.12% YoY)
  • Standalone PAT: ₹10.39 crore (up from ₹6.03 crore YoY)
  • Debt-to-Equity Ratio: 0x
  • Return on Net Worth: 16.80%

What to track next

Investors will monitor the company's ability to navigate global macro uncertainties and raw material price fluctuations in the upcoming fiscal year. Further updates on market strategies to mitigate concentration risks and the company's performance in its key segments will be crucial.

Investor Takeaway

Chembond Chemicals' strong revenue and profit growth in FY26, a debt-free status, and a dividend recommendation paint a positive picture for its independent journey. Investors should keep an eye on how the company manages external challenges and capitalizes on its growth opportunities.

Disclaimer:This article is published for informational purposes only. While reasonable efforts are made to ensure accuracy, completeness, and timeliness, readers are encouraged to independently verify information before making any decisions based on the content. The views and information presented are subject to editorial review and may be updated without notice.